SYLVANA GARCIA-MORALES: Open Payments
NPI 1699280099 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 48 payments from 11 companies in 2025. Trend: 2023 $869 · 2024 $971 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $431 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $219 |
| Otsuka America Pharmaceutical, Inc. | 11 | $156 |
| Lundbeck LLC | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| Alkermes, Inc. | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ABILIFY ASIMTUFII, COBENFY, AUSTEDO XR, Auvelity, ARISTADA.
Industry payments across NJ — which companies pay providers there.
